Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 502943884

Cayman Chemical ANTIBODY LMT-28 50mg
SDP

Catalog No. 502943884
Encompass_Preferred

An inhibitor of the gp130-IL-6/IL6Rα protein-protein interaction; binds to gp130 (Kd = 7.4 µM) and selectively inhibits IL-6-induced STAT3 phosphorylation over leukemia inhibitor factor- or phorbol 12-myristate 13-acetate-induced STAT3 phosphorylation in HepG2 cells at 10, 30, or 100 µM; reduces IL-6-induced increases in the viability of GM-CSF-starved TF-1 leukemia cells at 10 to 1,000 nM; inhibits the LPS- and AGE-induced increases in mRNA encoding Rankl, as well as inhibits increases in the phosphorylation levels of gp130, Stat3, and Jak2, in mouse MC3T3-E1 osteoblasts at 100 nM; decreases joint and paw swelling, as well as serum levels of COMP, SAP, and anti-collagen II antibodies, in a mouse model of collagen-induced arthritis at 0.25 mg/kg per day; reduces bone resorption height and volume in a rat model of type 2 diabetes peri-implantitis induced by LPS, P. gingivalis, and a high-fat and high-sugar diet at 0.23 mg/kg per day p.o.

Catalog No. 50-294-3884 Supplier Cayman Chemical Supplier No. 4083750 MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

An inhibitor of the gp130-IL-6/IL6Rα protein-protein interaction; binds to gp130 (Kd = 7.4 µM) and selectively inhibits IL-6-induced STAT3 phosphorylation over leukemia inhibitor factor- or phorbol 12-myristate 13-acetate-induced STAT3 phosphorylation in HepG2 cells at 10, 30, or 100 µM; reduces IL-6-induced increases in the viability of GM-CSF-starved TF-1 leukemia cells at 10 to 1,000 nM; inhibits the LPS- and AGE-induced increases in mRNA encoding Rankl, as well as inhibits increases in the phosphorylation levels of gp130, Stat3, and Jak2, in mouse MC3T3-E1 osteoblasts at 100 nM; decreases joint and paw swelling, as well as serum levels of COMP, SAP, and anti-collagen II antibodies, in a mouse model of collagen-induced arthritis at 0.25 mg/kg per day; reduces bone resorption height and volume in a rat model of type 2 diabetes peri-implantitis induced by LPS, P. gingivalis, and a high-fat and high-sugar diet at 0.23 mg/kg per day p.o.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.